Femasys News

EXCLUSIVE: Femasys At Inflection Point And Undervalued, Expects Growth Potential Following Roe V. Wade Overturn, CEO Says

Femasys Inc (NASDAQ:FEMY) is a biomedical company focused on women's healthcare.The company, with a market capitalization of $22.50 million as of data from Benzinga Pro on 17 June, went public in June

BenzingaJun 17 03:22 ET

Femasys Is Putting Women in Charge of Their Reproductive Health

Cheddar NewsMay 14 12:17 ET

Femasys's Buy Rating Affirmed by Analyst Jason McCarthy on FemaSeed's Market Success and Robust Clinical Trials

TipRanksMay 11 11:45 ET

Express News | Femasys Inc : H.c. Wainwright Raises Target Price to $13 From $12

ReutersMay 10 02:18 ET

Express News | HC Wainwright & Co. Reiterates Buy on Femasys, Maintains $13 Price Target

BenzingaMay 9 13:40 ET

Analysts Offer Insights on Healthcare Companies: Hookipa Pharma (HOOK) and Femasys (FEMY)

TipRanksMay 9 12:40 ET

Femasys | 10-Q: Quarterly report

SEC announcementMay 9 08:42 ET · Announcements

Express News | Femasys Q1 2024 GAAP EPS $(0.17) Beats $(0.19) Estimate, Sales $271.140K Miss $776.500K Estimate

BenzingaMay 9 08:41 ET

Express News | Femasys Inc - Believe We Have Sufficient Cash to Fund Operations Into Second Half of 2025

ReutersMay 9 08:38 ET

Earnings Flash (FEMY) FEMASYS Reports Q1 Revenue $271,140

08:34 AM EDT, 05/09/2024 (MT Newswires) -- Earnings Flash (FEMY) FEMASYS Reports Q1 Revenue $271,140

MT NewswiresMay 9 08:34 ET

Femasys 1Q Sales $271,140 >FEMY

Femasys 1Q Sales $271,140 >FEMY

Dow JonesMay 9 08:31 ET

Express News | Femasys Announces Financial Results for Quarter Ended March 31, 2024 and Provides Corporate Update

ReutersMay 9 08:30 ET

Express News | Femasys Inc. Q1 EPS USD -0.17

ReutersMay 9 08:30 ET

Femasys Releases Updated Investor Presentation Information

TipRanksApr 24 09:22 ET

Femasys: A Buy Rating on Innovative Reproductive Solutions and Market Expansion Potential

TipRanksApr 2 15:45 ET

Femasys Price Target Maintained With a $12.00/Share by Chardan Capital

Femasys Price Target Maintained With a $12.00/Share by Chardan Capital

Dow JonesApr 1 08:35 ET

Femasys Is Maintained at Buy by HC Wainwright & Co.

Femasys Is Maintained at Buy by HC Wainwright & Co.

Dow JonesApr 1 06:54 ET

HC Wainwright & Co. Maintains Buy on Femasys, Raises Price Target to $12

HC Wainwright & Co. analyst Emily Bodnar maintains Femasys (NASDAQ:FEMY) with a Buy and raises the price target from $10 to $12.

BenzingaApr 1 06:43 ET

Femasys Full Year 2023 Earnings: EPS Beats Expectations, Revenues Lag

Yahoo FinanceMar 31 09:06 ET

Femasys Q4 EPS $(0.19) Beats $(0.21) Estimate, Sales $213.11K Miss $240.00K Estimate

Femasys (NASDAQ:FEMY) reported quarterly losses of $(0.19) per share which beat the analyst consensus estimate of $(0.21) by 9.52 percent. This is a 20.83 percent increase over losses of $(0.24) per s

BenzingaMar 28 23:38 ET